Clinical Trial: Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Clinical Study to Evaluate the Safety and Efficacy of Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Cerebellar Ataxia .It is Self Funded (Patients' Own Funding) C

Brief Summary: Cerebellar ataxia is a complex motor disturbance, which, can occur as a result of many diseases and presents with symptoms of an inability to coordinate balance, gait, extremity and eye movements. Lesions to the cerebellum can cause dyssynergia, dysmetria, dysdiadochokinesia, dysarthria and ataxia of stance and gait. Deficits are observed with movements on the same side of the body as the lesion (ipsilaterally).

Detailed Summary:
Sponsor: Chaitanya Hospital, Pune

Current Primary Outcome: improve in INTERNATIONAL CO-OPERATIVE ATAXIA RATING SCALE [ Time Frame: baseline and after 12 month ]

To see improvement in INTERNATIONAL CO-OPERATIVE ATAXIA RATING SCALE when compare with baseline and after 12 month.


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Balance test [ Time Frame: baseline and after 12 MONTH ]
    To see improvement in Balance test when compare with baseline and after 12 month.
  • Tremor Rating Scale [ Time Frame: baseline and after 12 MONTH ]
    compare the pre and post Tremor Rating Scale
  • quality of life [ Time Frame: baseline and 12 months ]


Original Secondary Outcome: Same as current

Information By: Chaitanya Hospital, Pune

Dates:
Date Received: July 31, 2013
Date Started: September 2014
Date Completion: December 2016
Last Updated: September 16, 2014
Last Verified: September 2014